November 2025 Stock Watch List

As I'm writing this blog post, it's Friday, October 3rd. The temperature here in Central Wisconsin is set to reach a high of 87 degrees Fahrenheit later today. Better yet, a partly sunny forecast is predicted throughout today. Unsurprisingly, I'm going to be spending time outside today.

I have already deployed my initial capital for this month. So, I'm likely done with capital deployment for the month. That's why I will be turning my attention to potential stock buys for November 2025. Without further ado, let's jump into it!

Stock #1: Carlisle Companies (CSL)

Initially, my plan was to run back MercadoLibre from my October 2025 Stock Watch List blog post. However, I found out that Charles Schwab doesn't support fractional shares for any companies besides S&P 500 index constituents. As a result, I have pivoted to Carlisle Companies.

In my September 2025 Stock Purchases blog post, I outlined the gist of my investment thesis. Aging U.S. infrastructure and CSL's history of savvy bolt-on acquisitions are growth tailwinds. The company's investment-grade balance sheet and low dividend payout ratio give it flexibility for more bolt-on acquisitions in the future. I also believe CSL's dividend is positioned for double-digit percentage growth. At the $332 share price, the stock is priced at a P/E ratio of 15.3. This is significantly less than the 10-year average P/E ratio of 20.5 and my fair value of $400 a share (18.5 P/E ratio).

Stock #2: Novo Nordisk (NVO)

The next stock on my watch list for next month is Novo Nordisk. Interested readers can find my investment thesis in my August 2025 Dividend Stock Purchases blog post.

I believe NVO's drug portfolio and pipeline. This is why I think the company can deliver strong annual earnings growth for the foreseeable future. NVO's balance sheet is nearly flawless, with an AA S&P credit rating. The 2.6% dividend yield is also well-covered. At the current $59 share price, the stock is trading at a forward 12-month P/E ratio of 15. That's well below the 10-year average P/E ratio of 27 and my fair value P/E ratio in the low-20 range ($84 a share).

Stock #3: ONEOK (OKE)

The third stock on my watch list for November 2025 is ONEOK. Curious readers can peruse my investment thesis on OKE in my October 2025 Stock Watch List blog post or my August 2025 Seeking Alpha article.

OKE continues to have catalysts to drive mid- to high-single-digit OCF per share growth in the coming years. The company's BBB S&P credit rating is another plus. Lastly, the stock is trading at a forward 12-month P/OCF ratio of 6.9 from the current $73 share price. OKE's 5.7% dividend yield is quite safe, too. This is less than the 10-year average P/OCF ratio of 9.7 and my fair value P/OCF ratio of 8.7 ($92 a share).

Concluding Thoughts:

There we have it. I'm running back OKE. I'm also eager to add to my stakes in CSL and NVO. Overall, I'm planning on a 45% weight for CSL, 30% weight for OKE, and 25% weight for NVO, respectively. These weights could provide a yield in the high-2% range, outsized growth potential, and meaningful valuation upside.

Discussion:

Are any of CSL, NVO, or OKE on your watch list for November 2025?

If not, what stocks are you considering buying next month?

I appreciate your readership and welcome your comments below!